Black patients more likely to experience MACE after ADT for prostate cancer
Black patients are more likely to experience adverse cardiovascular outcomes after systemic androgen deprivation therapy (ADT) for prostate cancer, according to a study published online June 18 in JACC: CardioOncology.
Jun 20, 2024
0
0